$WT

WT Maintained by Craig-Hallum -- Price Target Raised to $29.00

Craig-Hallum raised its price target for WisdomTree (WT) to $29.00 from $24.00, maintaining a 'Buy' rating. The stock is currently priced at $24.73, which GuruFocus deems 40.1% overvalued. WT has a GF Score™ of 82/100, showing strong performance but concerns over valuation. Insiders have sold $736,800 in shares recently, with no purchases.

Original reporting
Published Oct 2, 2026, 6:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 3, 2026, 8:29 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$WT
Bullish
medium confidence
Mentioned
$WT
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$WTBullishMed
01

Why it matters

The target raise may attract new buying interest, but valuation concerns and insider sales suggest caution.

02

Market read

Analyst upgrade provides a modest catalyst for WT; limited spillover to peers.

03

What to watch

Potential regulatory scrutiny of digital‑asset offerings and broader market volatility could dampen the upside.

Relevance 7/10Novelty 6/10Timing: today

Background

WisdomTree is a $3.75 B market‑cap U.S. asset manager known for ETFs and expanding into digital assets.

Company-level read

Ticker impact

$WTBullishMedium confidence
Context

Craig‑Hallum raised WisdomTree's price target from $24.00 to $29.00 and kept a Buy rating.

Expected impact

potential upward pressure as investors price in the higher target

Evidence & confidence

Target increase of ~21% signals analyst confidence, but valuation concerns and insider sales temper the bullish case.

Market effects

May lift sentiment in the asset‑management/ETF sector as analysts view the space favorably.

Limited to U.S. listed asset managers; no broader regional effect.

Minimal global impact beyond investors tracking U.S. financial‑services stocks.

Counterpoint

High valuation (P/E 47x) and insider sell‑off could signal over‑optimism; downside risk if price corrects.

Key entities

  • Craig‑Hallum

    Research firm that issued the rating update.

  • WisdomTree (WT)

    U.S. asset‑management firm specializing in ETFs.

Related articles

$WTMed

WisdomTree (WT) Stock Is Up, What You Need To Know

WisdomTree (WT) stock rose 2.9% after Goldman Sachs increased its price target to $21.30, citing improved earnings and industry outlook. Shares later settled at $24.40, up 1.5% from the previous close. WT has seen volatility, with 11 moves over 5% in the past year. The stock is up 95% YTD, near its 52-week high of $25.04.

$WTMed

WT Maintained by Goldman Sachs -- Price Target Raised to $21.30

Goldman Sachs maintained a Neutral rating on WisdomTree (WT) but raised its price target to $21.30 from $18.30. GuruFocus values WT at $17.65, suggesting a 41% overvaluation. The company has a GF Score of 82/100, with strong profitability and growth but low valuation metrics. Insiders have sold $736,800 worth of shares in the last three months.

$WTMed

Should You Buy WisdomTree (WT) Stock After Its Latest Crypto Move?

WisdomTree (WT) reported record AUM of $162.9B in Q2 2026, up 30% YoY, with revenue at $177.2M and 40.5% operating margin. The company partnered with MoonPay to integrate its tokenized fund WTGXX, accessing 35M accounts. Despite GAAP losses from debt repurchases, management highlights long-term growth potential in digital assets. WT trades at a forward P/E of 17.30.

$WTMed

WisdomTree Announces Second Quarter 2026 Results

WisdomTree, Inc. (WT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 WisdomTree Announces Second Quarter 2026 Results Record AUM of $162.9 Billion Diluted Earnings Per Share of $0.28; Adjusted Earnings Per Share of $0.31 13% Annualized Organic Flow Growth Rate Operating Margin Expanded by 780 bps Year over Year; or 900 bps, on an Adju

$WTMed

WisdomTree (NYSE:WT) Delivers Strong Q2 CY2026 Numbers

Asset management firm WisdomTree (NYSE: WT) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 57.3% year on year to $177.2 million. Its non-GAAP profit of $0.31 per share was 17.3% above analysts’ consensus estimates. Is now the time to buy WisdomTree? Find out by accessing our full research report, it’s free. "The second quarter demonstrated the quality of WisdomTree's growth.

$WTMedAI 8/10

WisdomTree (WT) Launches Physical AI, Humanoids, Drones ETF (WDRN) Focused on Real-World Automation

WisdomTree (NYSE:WT) launched the Physical AI, Humanoids, and Drones ETF (WDRN) on May 14, targeting companies applying AI to physical tasks. The fund has a 0.45% expense ratio and focuses on humanoid robotics, autonomous drones, smart manufacturing, and logistics automation, using a rules-based, quarterly rebalanced index. The report says it aims to track the shift from digital AI to real-world automation.